(Q51193840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mathew Diggle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Timothy J Mitchell

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Karen E. Lamb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

10

Jim McMenamin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Donald Inverarity

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

David Greenhalgh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Johanna M Jefferies

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Andrew Smith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Giles F S Edwards

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Barbara Denham

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Eisin McDonald

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Stuart C Clarke

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Chris Robertson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

24 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

4356-4363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806244%20AND%20SRC:MED&resulttype=core&format=json

Temporal and Geographic Stability of the Serogroup‐Specific Invasive Disease Potential of Streptococcus pneumoniae in Children

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Pneumococcal capsular polysaccharide structure predicts serotype prevalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Clonal Relationships between Invasive and Carriage Streptococcus pneumoniae and Serotype‐ and Clone‐Specific Differences in Invasive Disease Potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Streptococcus pneumoniae serotype 19A in children, South Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal Vaccination for French children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Temporal Analysis of Invasive Pneumococcal Clones from Scotland Illustrates Fluctuations in Diversity of Serotype and Genotype in the Absence of Pneumococcal Conjugate Vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Serotyping of Streptococcus pneumoniae strains by coagglutination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Automated PCR/Sequence Template Purification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Automated pneumococcal MLST using liquid-handling robotics and a capillary DNA sequencer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Molecular typing of the pneumococcus and its application in epidemiology in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079

Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.079